Kings Path Partners »

Ligand Pharmaceuticals In shares owned by Kings Path Partners

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Kings Path Partners from 13F filings

Historical chart of Kings Path Partners investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Kings Path Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Kings Path Partners

Quarter filed Position value Share count Share price at filing
2025-06-30 $576k 5.1k 113.68
2025-03-31 $533k 5.1k 105.14
2024-12-31 $885k 8.3k 107.15
2024-09-30 $827k 8.3k 100.09
2024-06-30 $580k 6.9k 84.26

More positions owned by Kings Path Partners

Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Global Core Plus (DFGP)
Schwab Strategic Tr Us Tips Etf (SCHP)
Vanguard Malvern Fds Core Bd Etf (VCRB)

View all positions for Kings Path Partners

Top funds holding Ligand Pharmaceuticals In

Tudor Investment Corporation
BlackRock
Vanguard Group
Henderson Group
Macquarie Group
State Street Corporation
Congress Asset Management
Chicago Capital
Stephens Investment Management Group
Massachusetts Financial Services
Dimensional Fund Advisors
Geode Capital Management
FMR
Loomis, Sayles and
Invesco

View all funds holding Ligand Pharmaceuticals In